This summary was created by AI, based on 2 opinions in the last 12 months.
Coloplast A/S (CLPBY-OTC) is a leading Danish company in ostomy care, continence care, and wound care. Despite a temporary weakness in 2023, the company has shown robust organic growth of 8-9% per year. With a strong dividend and high growth potential, Coloplast is recognized as a leader in its space. The company has also made significant acquisitions and investments in research and development, indicating a positive outlook for future growth. Overall, experts see Coloplast as well-positioned for continued success in the healthcare industry.
It is a Danish company which is a global leader in ostomy care and continence care, and third largest in wound care. It has done two big acquisitions. It has had some weakness in 2023 but should grow through good M&A and good R&D. It has had an 11% dividend growth rate per year and 12% share growth rate per year. Buy 9 Hold 15 Sell 3
(Analysts’ price target is $841.23)(A Top Pick August 21/17, Up 24%) Colostomy bags and catheters, playing the aging demographic. Gained market share in US. Free cash flow is above competitors. Dividend grows about 10-15% per year. Investors go here to hide, so it goes up when markets go down. Buy on a pullback.
Colostomy bags. The demographics are such that gastrointestinal disorders are among the bigger problems dealing with the retirees of the world. If you get a company this size growing this fast without acquisitions you have a good company. They have a history of dividend increases. (Analysts’ target: DKK 553.00).
Coloplast A/S is a American stock, trading under the symbol CLPBY-OTC on the US OTC (CLPBY). It is usually referred to as OTC:CLPBY or CLPBY-OTC
In the last year, there was no coverage of Coloplast A/S published on Stockchase.
Coloplast A/S was recommended as a Top Pick by on . Read the latest stock experts ratings for Coloplast A/S.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
0 stock analysts on Stockchase covered Coloplast A/S In the last year. It is a trending stock that is worth watching.
On 2024-04-22, Coloplast A/S (CLPBY-OTC) stock closed at a price of $12.95.
Prices fell hard in 2022, but has partially come back as underlying growth has been robust at 8-9% organic growth in revenue per year. It pays a 2.3% dividend and offers high growth. Are the leaders in their space.